C4 Therapeutics, Inc. reported that Mark Mossler is stepping down as Chief Accounting Officer effective May 15, 2026, with Kendra R. Adams taking over the role without additional compensation. This change is not due to any disagreements; the effective date of Mark's departure is May 15, 2026.